1Silber S,Albertsson P,Aviles FF,et al.Guidelines for percutaneous coro-nary interventions.The Task Force for percutaneous coronary interven-tions of the European society of Cardiology.Eur Heart J,2005,26:804-847.
2Montalescot G,Barragan P,Wittenbery O,et al.For the ADMIRAL investigators.Platelet glycopretion Ⅱb/Ⅲa inhibition with coronary stenting for acute myocardial infarction.N Eng J Med,2001,21:1895-1903.
3Lee DP,Herity NA,Hiatt BL,et al.Adjunctive platelet glycoprotein Ⅱb/Ⅲa inhibition with tirofiban before primary angioplasty improves angiographic outcome:Results of the Tirofiban give in the Emergency Room before primary angioplasty (TIGER-PA) pilot trial.Circulation,2003,107:1497-1501.
4The TIMI study group.The thrombolysis in myocardial infarction (TIMI) trial;phase I findings.N Engl J Med,1985,312:932-936.
2Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coro- nary interventions. The Task Force for Percutaneous Coronary Interven- tions of the European Society of Cardiology. Eur Heart J, 2005,26 : 804- 847.
3Giri S, Mitchel JF, Hirst JA,et al. Synergy between intracoronary stenting and abciximab in improving angiographic and clinical outcomes of prima- ry angioplasty in acute myocardial infarction. Am J Cardiol, 2000,86: 269-274.
4Seydoux C, Goy JJ, Davies G. Platelet and neutmphil imaging techniques in the investigation of the response to thrombolytic therapy and the no-re- flow phenomenon. Am Heart J, 1993,125 : 1142-1147.
